SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treatment " 1,570 found 🔀 AI-powered Shuffle
Verana Health Introduces Significant Data and AI Enhancements to Support Ophthalmologic Research and Treatment Optimization
/PRNewswire/ -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD),...
Global Health & WASH: October 2026 Funding Opportunities (26 new opportunities)
41 opportunities on the Global Health & WASH page this cycle, 26 of them new. The health money on this page is mostly research money, and much of it is aimed at people early in their careers. Funder after funder, from the TANGO2 Research Foundation’s Research Pathways grants to the South African Medical Research Council’s Early Investigators Programme to the National Ataxia Foundation and Alex’s Lemonade Stand Foundation, is funding early-career investigators and the institutions that host them, with a clear tilt toward researchers based in or from the Global South, from AMBSO in Uganda to Kenya’s CONNECT-VAX network to Ersilia’s AI Incubator for African drug discovery. The money is organized by disease as much as by need: narrow foundations, the Parkinson’s Foundation, NTAP for neurofibromatosis, the RUNX1 Research Program for an inherited blood disorder, each run their own grant, so the question for an applicant is less which health problem you work on than which foundation owns your disease. The largest European cheques go to consortia only, with the European Innovation Council putting up to EUR €4 million behind a single healthy-ageing project and UNITE up to EUR €1 million behind each cross-border digital health team. Water sits apart, almost entirely in applied utility research: the Water Research Foundation’s cluster of USD $250,000 to $500,000 projects, each built around a utility problem from sewer laterals to reuse treatment. And the biggest single pot is public: HRSA is renewing community health center service areas with awards of up to USD $10 million each. This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Opportunities 2027 Building the Field of Health Advocacy Grant, Georgia Health Initiative. *New!* *Closing soon!* Georgia Health Initiative, a nonprofit private foundation focused on health equity, is opening its 2027 Building the Field of Health Advocacy Grant to strengthen the organizations that push for healthier systems across the state. The Initiative treats advocacy as infrastructure, backing one-year projects that range from urgent responses to shifting federal policy to longer arc campaigns on housing, behavioral health, care access, and food security. It wants coalitions that elevate community voice, apply an equity lens, and arrive ready to deploy concrete strategies, and it deliberately seeks variety in issues, communities, and organizational size. The optional webinar and required lobbying training signal a funder investing in a durable field, not one grant cycle. The strongest fits are Georgia nonprofits and public agencies ready to turn advocacy readiness into systems change. Geographies: United States. Who can apply: Tax-exempt 501(c)(3) public charities, state or local government agencies, or coalitions/collaboratives using a 501(c)(3) fiscal sponsor, that work in Georgia on behalf of Georgians and align with the mission, vision, and values of Georgia Health Initiative. Only one application per organization, though an organization may be listed as a partner or subcontractor on multiple applications. Funding amount: Organizations can apply for up to USD $80,000 per project; the Initiative anticipates investing a total of USD $1.36 million. Targeted Sectors / SDGs: Governance, Policy & Advocacy · SDG3; SDG10. Deadline: October 2, 2026. Learn more and apply here. TDD Research Pathways Grant, TANGO2 Research Foundation. *New!* *Closing soon!* The TANGO2 Research Foundation, working with a founding gift from Tango2UK, is opening its TDD Research Pathways Grant to fund early-career investigators anywhere in the world who study TANGO2 Deficiency Disorder. The foundation is using this money to seed pilot work and to build a research community around a rare disorder that few labs currently study. It wants to back emerging scientists, clinicians, and trainees who will stay with this field, not one-off projects, which is why it requires a committed mentor and real institutional support and asks each applicant for a plan for future contributions. The design rewards promise and persistence over track record. The strongest fits are students, residents, postdoctoral fellows, and new investigators ready to commit to TANGO2 research. Geographies: Global. Who can apply: Early-career investigators worldwide, including undergraduate, graduate, and medical trainees, postdoctoral fellows, residents, and clinical or research fellows. Early-career investigators must hold a PhD, MD, or equivalent doctoral degree and be within 10 years of that degree or within 5 years of initiating rare disease research, engaged in postdoctoral research at an academic institution, teaching hospital, or nonprofit research institute. Currently enrolled trainees and transitional PhD candidates beginning a postdoctoral appointment at a nonprofit institution by July 1, 2026 are also eligible. All applicants must identify a qualified mentor with relevant TDD or rare disease research experience and demonstrate institutional support. Funding amount: Up to USD $15,000. Targeted Sectors / SDGs: Innovation, Science & Technology. Deadline: October 2, 2026. Learn more and apply here. Call for Expression of Interest (EOI): AMBSO Impact Research Initiative, Africa Medical and Behavioral Sciences Organization (AMBSO). *Closing soon!* The Africa Medical and Behavioral Sciences Organization is inviting expressions of interest for its Impact Research Initiative, which funds early-stage pilot studies and proof of concept work on priority health challenges. AMBSO is a Ugandan research organization backing bold ideas that can grow into larger studies, and its tracks span antimicrobial resistance, epidemic preparedness, artificial intelligence for diagnostics, HIV prevention, climate and health, cancer, maternal and child health, and non-communicable diseases. The small award size and direct-cost-only rule point to a funder that wants evidence rather than overhead, and that favors projects able to attract follow-on money or use AMBSO’s own research infrastructure. Eligibility runs worldwide, welcoming researchers and institutions inside and outside Africa. The strongest fits are researchers with a feasible pilot that generates policy-ready evidence. Geographies: Global. Who can apply: Open worldwide to researchers, academic institutions, and research organizations whose work aligns with generating high-impact health evidence. Independent researchers are eligible if affiliated with an academic or research institution. Doctoral students are encouraged to apply as part of a research team led by a faculty Principal Investigator. Community-based organizations and other eligible entities may apply. Projects may be implemented inside or outside Uganda. Funding amount: Up to USD $10,000 per project, with no minimum funding threshold. Targeted Sectors / SDGs: SDG3. Deadline: October 2, 2026. Learn more and apply here. Entrepreneurs for Resilience 2027 (E4R27), Swiss Re Foundation. *Closing soon!* Swiss Re Foundation is opening the tenth edition of Entrepreneurs for Resilience, which backs healthcare social enterprises expanding affordable, quality primary care for low-income communities across low- and middle-income countries. The Foundation is using catalytic, blended funding plus multi-year advisory to take risk out of scaling, helping proven models reach more people sustainably rather than stay stuck at pilot size. It looks to back brick-and-click enterprises that pair physical care with digital tools and build affordability through savings, payments, or microinsurance, ideally integrated with public health systems. Requiring earned revenue, real customer scale, and gender-inclusive teams signals that this is growth capital for commercially serious ventures, not seed money. The strongest fits are established, revenue-generating healthcare enterprises ready to scale access for underserved populations. Geographies: Global. Who can apply: For-profit and hybrid healthcare social enterprises serving low-income and underserved populations in low- and middle-income countries, using combined physical and digital (brick-and-click) healthcare delivery models. Applicants must demonstrate measurable social impact, generate at least 50% of income through earned revenue, have been established no later than December 2023, already serve at least 50,000 people with potential to scale, and have at least 30% low-income customers. Preference for gender-inclusive enterprises with at least one female founder or at least 30% women in management. Funding amount: Pilot funding of up to USD $45,000 for the 6-8 shortlisted social enterprises; up to USD $1 million in blended funding (up to USD $600,000 unconditional plus up to USD $400,000 conditional) shared among 3-4 finalists over a two-year implementation period; total programme funding approximately USD $1.3 million. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG5. Deadline: October 4, 2026. Learn more and apply here. Horizon HealthTech 2026, IIITD Innovation & Incubation Center. *Closing soon!* IIITD Innovation and Incubation Center is opening Horizon HealthTech 2026, a nine-month MedTech incubation cohort run under the aegis of BIRAC EDGE for founders building medical devices, diagnostics, surgical and interventional tools, or remote monitoring. The center is backing teams that already hold a validated proof of concept and want to reach a tested prototype, pairing each founder with a named expert and clinical validation through a hospital partner. What they seek to back is Indian health technology that can survive real clinical scrutiny and regulatory review, not slideware. The structure, with lab access, CDSCO guidance, IP support, and investor connects, signals a program built to make startups ready for follow-on capital. The strongest fits are early-stage MedTech teams with defensible IP and a working path from bench to bedside. Geographies: India. Who can apply: Early-stage teams/startups with a validated idea/proof of concept (TRL 3 onwards) working on medical devices, diagnostics, surgical/interventional technologies, or remote monitoring, holding IP or with potential to generate IP. Funding amount: No cash award amount is stated on the official program page. Benefits are in-kind: prototyping lab and equipment access, clinical/hospital validation (Max Healthcare), expert mentorship, CDSCO regulatory guidance, IP filing support, workspace, cloud credits and tools, and investor connects. Run under the aegis of BIRAC EDGE and builds a path to follow-on Government/VC/Angel funding. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG9. Deadline: October 5, 2026. Learn more and apply here. OpenAI AI and Teen Development Research Grant Program, OpenAI. *New!* *Closing soon!* OpenAI is opening its AI and Teen Development Research Grant Program to fund independent studies of how generative AI shapes the lives of young people ages 13 to 17. OpenAI wants a stronger evidence base on how teens actually use these tools and what that use does to their social and emotional development, so that product teams, policymakers, and regulators can act on findings rather than assumptions. It seeks work on emotion regulation, relationships, belonging, and the safeguards that keep teens safer, welcoming interdisciplinary teams and any methodology. That it will fund research whose conclusions may not favor AI providers, and prioritizes studies touching ChatGPT, signals a genuine appetite for credible outside scrutiny. The strongest fits are research groups grounded in adolescent development, well-being, and AI safety. Geographies: Global. Who can apply: Researchers aged 18 or older who are affiliated with a research institution or organization, and/or have significant experience relevant to child or adolescent development, well-being, human-computer interaction, AI impacts, or a closely related field. Multiple institutions may collaborate. OpenAI is seeking to fund research rather than for-profit initiatives and will not prioritize for-profit organizations. Funding amount: Individual research grants up to USD $1 million, totaling up to USD $5 million; maximum 10% of each grant for overhead or indirect costs. Targeted Sectors / SDGs: Social Inclusion & Community Wellbeing; Innovation, Science & Technology. Deadline: October 6, 2026. Learn more and apply here.
Entertainment RX: Cancer treatment, concern for a gender-fluid grandchild
Entertainment RX, a new column from former Globe TV critic Matthew Gilbert, is an entertainment-guided advice column offering things to read, listen to, or watch that somehow address — or, in some cases, distract from — the issues readers write in about.
When science advances, understanding must keep pace
We are living in an era of extraordinary scientific progress. We can target diseases in ways that were unimaginable a generation ago, develop increasingly sophisticated medicines and explore entirely new approaches to treatment.
In 2021, Australian scientists sprayed wheat scent across farm plots to confuse hungry mice; the treatment reduced seed loss by up to 74% in a field experiment without poisoning the rodents
Australian scientists have tested a non-toxic way to protect wheat seeds from hungry mice by making it harder for the rodents to locate them. In an experiment carried out in 2021, instead of poisoning the mice or using bait, the researchers sprayed diluted wheat germ oil across farm plots to camouflage the smell of wheat seeds.
Advances in Oncology Treatment Are Changing the Way Cancer Is Detected and Treated at Broward Health
Dr. Sajive Aleyas performing the first case with the Ion Endoluminal System. Cancer care is evolving as researchers and physicians gain a deeper understanding of how cancer develops, progresses and responds to treatment. Advances in molecular testing, imaging, minimally invasive procedures and targeted therapies are giving physicians more information to guide decisions and patients access […]
For sleep apnea, a dental device may be as effective as CPAP
A dental device may be as effective as CPAP for some people with sleep apnea. Learn how oral appliances work and who may benefit from this treatment option....
What Does Your Office Say About Your Business? by Jennifer Kraner
What does your space say about you and your business? More importantly, does it give you the best possible first impression? The minute a client, customer or patient walks through your door, they’re forming an opinion about your business – sometimes consciously, sometimes without even realizing it. Your space is communicating something about you, whether you intend it to or not. At Big Sky Design, we work with all kinds of commercial businesses, including many medical practices, law firms and other corporate offices, and I’ve seen first hand how much thoughtful design can influence that first impression. For businesses in medical, legal, and financial fields, three things are particularly important: trust, privacy and professionalism. Your space should communicate all three while also reflecting who you are as a business. That can be challenging, especially in a new construction project. Often, so much of the budget goes toward the actual construction that things like lighting, comfortable seating, artwork and finishing touches get pushed to the side. But those are often the elements that make a space feel complete – and memorable. Think about your waiting room. Is it comfortable? Is the lighting welcoming? Does the layout make sense? When someone walks through the door, do they immediately know where to go and whom to speak with? In a medical office, there’s another important consideration: privacy. Reception areas can become surprisingly noisy places, with phone calls, conversations between staff and patients, and people discussing personal information. Hard surfaces throughout a space allow sound to bounce around, making it difficult to maintain privacy. We recently worked with an eye doctor's office that had exactly this problem. The reception desk had a large opening, and staff were making and taking phone calls right next to patients who were waiting. We designed an acoustic treatment that acted as a divider between the staff and waiting areas. It absorbed sound, but it also became a branded design element. It was a visual reminder to everyone in the space to be mindful of their voices and what others might be able to hear. Those kinds of thoughtful details can make a tremendous difference. And good commercial design doesn't have to mean making your space flashy. Sometimes it’s as simple as a calming color palette, beautiful artwork, plants, carefully selected lighting or comfortable upholstered furniture. In a medical setting, those touches can help soften what might otherwise feel clinical and reduce anxiety for patients who are already nervous about an appointment. I’ve been in waiting rooms where everyone feels packed together, and you can hear every conversation – even what’s happening in the restroom next door. That’s not the experience you want to create. Your office should also feel like your business. Are you telling people that you’re clean and modern? Sophisticated and unique? Warm and welcoming? Or, unintentionally, are you telling them that your business is outdated? You don’t necessarily need a complete renovation to change that message. Fresh paint, updated lighting, new artwork, better seating or a few branded design elements can make a space feel current and intentional. At Big Sky Design, we’ve worked with radiology, dermatology, and dental practices, among many others. Every practice is different, but the goal is always the same: creating a space that reflects the business behind it and gives every person who walks through the door a positive first impression. Because your office is part of your brand. Make sure it’s telling the story you want people to hear. Read more at bigskydesignonline.com.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
First Health System on West Coast to Use New Brain Bleed Technologies
Novel treatments may improve outcomes for chronic subdural hematoma, a common brain bleed, by enabling more complete artery closure.
Opinion | Blackwell: Missouri Must Address the Mental Health Crisis in County Jails
Every day, sheriffs, detention officers, nurses, and other jail staff across Missouri care for people whose serious mental illness requires treatment that a county jail was never designed to provide.
Jared Goldstein, M.D., Joins Baptist Health Urology
September 18, 2026 – Baptist Health is pleased to announce the addition of Jared Goldstein, M.D., a highly skilled urologist and urologic surgeon, to the Baptist Health Urology team. Dr. Goldstein brings to the community extensive expertise in general urology, minimally invasive surgery and men’s health services. Dr. Goldstein specializes in the diagnosis and treatment […]
Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist
September 3, 2026 – Baptist Health Wertheim Cancer Institute is pleased to welcome Kriti Ahuja, M.D., a board-certified medical oncologist specializing in breast cancer. Her clinical interests focus on the comprehensive treatment of patients with breast malignancies, while her research has explored breast cancer, cancer survivorship, second primary malignancies and novel cancer therapies. “We are […]
Nathan J. Nordmann, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spinal Oncology and Co-Director of Spinal Radiosurgery
August 27, 2026 – Fellowship-trained neurosurgeon Nathan J. Nordmann, M.D., has joined Baptist Health Miami Neuroscience as director of spinal oncology and co-director of spinal radiosurgery. He specializes in the surgical treatment of conditions affecting the brain and spine, with advanced expertise in primary and metastatic spinal tumors, complex spinal pathology and minimally invasive surgical techniques. […]
Harel Deutsch, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spine Surgery
August 24, 2026 – Fellowship-trained, board-certified neurosurgeon Harel Deutsch, M.D., has joined Baptist Health Miami Neuroscience Institute as director of spine surgery. An internationally recognized leader in spinal surgery, Dr. Deutsch specializes in minimally invasive spine surgery, motion preservation surgery and the treatment of failed back surgery syndrome. He brings nearly three decades of experience […]
Exhaling may speed up reaction times
Scientists testing potential treatments for sleep apnea made an unexpected discovery. How quickly people react may depend on whether they’re breathing in or out.
IVF ‘add-ons’ offer hope to parents desperate for a baby. But are they backed by science?
There’s little evidence that many IVF “add-on” treatments work. Should they even be offered?
New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
Perez Hilton reunites with children for 'short, supervised visits'
Perez Hilton has been able to see his children for 'short, supervised' visits while he undergoes treatment for his August mental health crisis.
Exercise helps Via Christi cancer patients take charge of their health
The American Cancer Society says regular exercise can improve a patient’s quality of life, give them more energy, and help them better deal with the side effects of treatment.
There's a cure for one of California's biggest health problems. Getting it is another matter
California is eliminating a key insurance hurdle for hepatitis C treatment, part of a broader push to get a long-available cure to the hundreds of thousands of patients who need it.
Hawaii Business Leaders Unite to End Alzheimer’s
With breakthroughs in brain health, detection and treatment, Hawaii leaders are coming together at a pivotal moment in the fight against Alzheimer’s.
Science takes the runway: HIV Unwrapped at NYFW
At this year’s New York Fashion Week, HIV Unwrapped has put science on the runway, calling attention to today’s breakthrough treatments, the U=U message, and the HIV/AIDS epidemic that forever changed New York’s art and cultural scene
ABC News' Will Reeve reveals testicular cancer diagnosis, chemotherapy treatment
ABC News' Will Reeve is seen on the set of 'Good Morning America' on June 9, 2026, on ABC. (Paula Lobo/ABC via Getty Images)
Federal judge upholds Idaho law that bans vaccine, medical treatment requirements in daycares
The ruling upholds an Idaho law that bans daycares, businesses, governments and schools from mandating vaccines or “medical interventions."
The last ‘breakthrough’ devices to get special treatment from Medicare
New medical devices deemed "breakthrough" by the FDA are no longer automatically eligible for extra Medicare payments.
‘The story is always the same’: NC officials confront broken involuntary commitment system
State leaders are pursuing reforms to cut unnecessary commitments, expand voluntary treatment and improve follow-up mental health care.
Could psychedelic therapy become NHS treatment for mental health?
Could hallucinogenic drugs become part of mainstream NHS care to treat depression?
UConn Health Launches Cutting-Edge CAR-T Cell Therapy Program
New program brings potentially lifesaving treatment for certain blood cancers closer to patients in Connecticut and the region.
Redmond youth mental health facility to break ground Tuesday
Construction on an in-patient youth mental health treatment facility in north Redmond will begin Tuesday. And health care providers say it will fill a much-needed hole in Central Oregon’s health […]
Reimagining the treatment of mental health: Maria Carolina Bittencourt Gonçalves
By Jessica Leff Listen to Maria tell her story | Wyss Institute · Maria C. B. Gonçalves – Reimagine the WorldMaria Carolina Bittencourt Gonçalves, Ph.D., grew up in São Paulo, Brazil, the largest city by population in South America. It’s comparable to New York, but with a tropical climate. “I knew I wanted to be...
Providence Alaska Launching Residential Youth Behavioral Program
To expand psychiatric treatment for teenagers, Providence Alaska is opening a Youth Behavioral Health Center in Anchorage this fall.
Health issues or legal strategy? Defense and prosecutors clash over Cilia Flores’s condition
While lawyers for the wife of Nicolás Maduro claim she suffers from heart and gastric problems, the U.S. Attorney’s Office says the defendant has refused medical treatment, according to court filings
Turtle Beach Afterglow review: A Switch 2 controller with the full RGB treatment
This is for the gamer who wants RGB everything.
Rocking Tree Farm boards pets for veterans in mental health care
A local nonprofit, Rocking Tree Farm, is helping veterans get the mental health treatment they need by making sure they don't have to leave their pets behind.
New UMSOM Research Shows Promising Results for Health Care Professionals Using Ketogenic Diet Therapy to Treat Mental Illness
Specialized high-fat, low carbohydrate diets, known as ketogenic metabolic therapy, are showing promising therapeutic benefits for certain mental illnesses in emerging research. Now, a new study from researchers at the University of Maryland School of Medicine’s Maryland Psychiatric Research Center (MPRC) shows that an immersive training program can improve health care provider confidence in using a ketogenic dietary treatment plan for their patients.
'The right diagnosis is unbelievably powerful': It can take years to diagnose rare diseases, and scientists are trying to fix that
Tens of millions of Americans live with rare or undiagnosed diseases. These scientists are working to deliver them better diagnostics and treatments.
Milwaukee County promised mental health help. Instead, her son landed in jail
His parents warned Milwaukee County that TJ had stopped treatment. Weeks later, his mental health crisis ended in jail.
Chronic disease is an economic problem as well as a health crisis
Employers and health systems can work together to improve prevention, screening and treatment – but sustained funding and better coordination are essential.
From professor to patient: One man's journey on the frontier of lung cancer treatment
Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.
In California, IVF insurance haves and have-nots
Landmark legislation requiring large employers to cover infertility treatments went into effect at the beginning of the year. It’s changed lives and boosted clinic caseloads – and left the uninsured scrambling to afford care.
The Trump administration said it would prioritize ending mother-to-child HIV transmission. Health workers say it cut services
Dr. Theopista Masenge was at the hospital in Mbeya, Tanzania, rolling out new treatments for children with high HIV viral loads when she got the call: Stop work, now.
Why rheumatoid arthritis pain may persist even when inflammation is under control
Pain and fatigue in rheumatoid arthritis can persist even after inflammation improves, with depression, poor sleep, obesity, smoking, and chronic pain potentially helping sustain symptoms. Researchers say identifying these hidden drivers could prevent unnecessary medication changes and lead to more personalized treatment.
Is CVS Health (CVS) Cheap As Renewables And Cancer Care Expansion Lift Optimism?
CVS Health (CVS) has put sustainability and access to care in focus, committing to source 50% of its electricity from renewables by 2040, while Aetna expands bundled cancer treatment authorizations for Medicaid members. Recent headlines around CVS Health’s renewable energy push and Aetna’s broader cancer care bundles have landed alongside a 1-year total shareholder return of 21.37% and a 3-year total shareholder return of 43.14%. At the same time, the 90-day share price return has declined...
Joliet gets $1 million federal grant for community mental health program
The funds are part of more than $3.17 million in federal grants for Will County programs related to childcare, nursing education, substance abuse treatment, and university research, according to Rep. Lauren Underwood's office.
Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive treatments for obesity and diabetes.
Global health summit in Saranac Lake tackles the shifting threat of dengue fever
The Trudeau Institute hosted a summit to discuss ongoing evaluation of treatments for the battle against dengue fever.
Cottage Health Hosts Sepsis Conference Focused on Early Recognition and Treatment
Cottage Health brought together physicians, nurses, pharmacists, respiratory care practitioners and other clinicians from across the region on Friday,
Presley Gerber cremated after death at treatment center: Report
Presley Gerber's body has been cremated in the Los Angeles area days after the model died at 27 in a rehabilitation center, according to TMZ.
Paid Leave Oregon offers up to 12 weeks for mental health, substance use treatment
Workers may qualify for Paid Leave Oregon during substance use and mental health treatmentSalem, Ore. — During National Recovery Month, Paid Leave Oregon is rem
Senate approves legislation targeted at pilot, air traffic control mental health guidance
The Senate passed two bills Thursday aimed at removing barriers for pilots and air traffic controllers seeking mental health treatment, as well as reduce stigma surrounding the conditions. Sponsore…
HHS Awards Almost $250 Million to Expand Addiction Treatment, Overdose Prevention and Mental Health Services
SAMHSA, an agency within HHS, awarded $247.9M in grants to support addiction treatment, mental health services, and recovery programs.
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time gene therapy for Sanfilippo syndrome type A, an inherited disease that progressively destroys cognitive function in young children. Until this week, there was no approved treatment at all. BioNTech’s lung cancer candidate shows promising results. […]
The 28 Most Expensive and Must-Have Cards in Reality Fracture
Reality Fracture is bringing the heat as the last in-universe set of 2027, and with the set comes a ton of new art styles and booster fun treatments, plus some big-money cards you'll want to be on the lookout for.
US Senate approves legislation to address pilot, air traffic control mental health issues
WASHINGTON, Sept 25 (Reuters) - The US Senate approved bipartisan legislation to modernize regulations on mental health guidance for pilots and air traffic controllers to encourage early disclosure and treatment. Commercial airline pilots often c...
US Senate approves legislation to address pilot, air traffic control mental health issues
The US Senate approved bipartisan legislation to modernize regulations on mental health guidance for pilots and air traffic controllers to encourage early disclosure and treatment.
US Senate Approves Legislation to Address Pilot, Air Traffic Control Mental Health Issues
WASHINGTON, Sept 25 (Reuters) - The US Senate approved bipartisan legislation to modernize regulations on mental health guidance for pilots and air traffic controllers to encourage early disclosure and treatment. Commercial airline pilots often conceal mental health conditions for fear ...
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “NewCo” model. In a lawsuit originally filed in New York state court and recently moved to federal court, China’s Lepu Medical Technology has alleged that biopharma business development consultant Su Zhang, who was hired to help shop its GLP-1 weight-loss candidates to Western partners, engaged in corporate double-dealing and trade secret leaks. According to the complaint, while acting as Lepu’s primary dealmaking liaison for a group of obesity and metabolic disease drug candidates, Zhang was secretly double-dipping as the acting chief business officer for a direct competitor, BrightGene Pharmaceutical. “She never adequately disclosed the role, never sought Lepu’s consent, and never proposed any safeguard,” Lepu alleged in its complaint, which was filed in July after Zhang’s consulting firm, CoDevCo, sought certain transaction-based success fees from its angry customer through an arbitration process in Singapore. Lepu, the parent company of Lepu Biopharma, has asked Zhang to pay back its $500,000 retainer and disgorge all benefits she received during the alleged breaches of fiduciary duty, plus other damages and relief. The company has also requested the court grant injunctions to protect Lepu’s trade secrets. The ill-fated partnership officially kicked off in December 2024, when Lepu tapped CoDevCo as its “exclusive business development mechanism” to identify collaborators for the company’s drug candidates. According to Lepu’s complaint, Zhang personally negotiated and signed the agreement as managing director for CoDevCo, which used her home address. Before the Lepu deal, Zhang made a name following a short stint as the global head of business development for Hengrui Pharmaceuticals. It was during her tenure that Hengrui signed a landmark deal granting exclusive rights for a portfolio of GLP-1 assets to Hercules, which was at that time newly established by a group of private equity and venture capital firms. In addition to the regular upfront and milestone payments, Hengrui also gained an equity stake in Hercules, which later became Kailera Therapeutics. The Hengrui-Hercules deal opened a new paradigm, where a Chinese biopharma company spins off certain early-stage assets to investors for further development through the creation of a new company abroad. The “NewCo” model quickly came into vogue as it allows Western investors to access high-potential assets originating from China at an early stage while giving the Chinese licensors an opportunity to reap long-term benefits through equity stakes in the new firms. The NewCo model proved its value when Kailera staged a record-breaking $625 million IPO on Nasdaq this April, merely two years into the Hengrui deal. Related Kailera CEO 'knew we were in a good spot' before obesity biotech's record-breaking $625M IPO On her LinkedIn page, Zhang described her work at Hengrui as “[b]uilding team and capability from the ground up,” forming NewCo and major pharma partnerships worth billions of dollars. Lepu clearly wanted that kind of track record to help boost its own cardiometabolic portfolio, which includes a range of assets for obesity, Type 2 diabetes, fatty liver disease and muscle preservation during weight loss treatment. “Lepu’s pipeline is very valuable, but only if Lepu could secure the right international partner to expand into the overseas market during the available commercial window,” the company argued in its complaint. The Chinese biotech said it had little knowledge of U.S. laws, customs or business practices in the business development field, and therefore “needed to rely entirely” on the expertise of Zhang and her team as the firm’s first engagement of a U.S.-based BD consultant. “Zhang’s dominating influence on the business development strategy is further evidenced by the fact that she personally controlled the business-development communications on behalf of Lepu with potential partners,” Lepu said in its complaint. After entering the deal, Zhang introduced Lepu to her four associates. According to Lepu’s version of events, all of them were allegedly employed at different time points to perform similar jobs at other Chinese companies that Lepu described as its competitors, while having access to Lepu’s confidential information. As such, Lepu described Zhang’s team as “a roster of individuals whose primary professional loyalty, by virtue of their concurrent full-time employment, ran to Lepu’s competitors.” As well as the specific examples set out in the case, a look at Lepu’s deals over the period suggests Zhang may have been involved in at least one transaction. During their partnership, Lepu, through its subsidiary Shanghai Minwei Biotechnology, also out-licensed its GLP-1/GIP/FGF21 agonist MWN105 to a NewCo called Sidera Bio in the fall of 2025. The deal included an upfront and near-term payment of $35 million, up to $1.01 billion in milestones, and a 9.99% stake in the Danish startup. It seems likely that Zhang facilitated the Minwei deal given that Lepu is on record as having used CoDevCo as its “exclusive business development mechanism.” The big shock for Lepu came in the form of a news article on June 25, 2025. The article, reporting on phase 2 data for BrightGene’s GLP-1/GIP receptor agonist BGM0504, identified Zhang as acting chief business officer of the Lepu rival. Blindsided by her association with BrightGene, Lepu confronted Zhang in July 2025. “Lepu was given assurances that there was nothing to be concerned about and told that Zhang would explain the matter to Lepu,” Lepu alleged in its complaint. “Zhang never did.” Lepu claimed that Zhang had the motive and opportunity to steer potential prospective partners toward BrightGene or other competitors. Later, in February 2026, one of Zhang’s associates joined BrightGene as the vice president for global business development, according to the complaint. Around the same time, Lepu sent written demand letters asking Zhang to account for her BrightGene role, identify what confidential data were shared with the rival firm, and provide any conflict-of-interest or firewall policies during the engagement. According to Lepu, neither CoDevCo nor Zhang answered the questions in their responses. Related Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight In a motion to dismiss filed with the U.S. District Court in the Eastern District of New York on Sept. 4, Zhang’s legal team argued that Lepu’s agreement was signed with CoDevCo, and that an employee of the contractor does not owe fiduciary duties to the client. In its complaint, Lepu said: “That CoDevCo was the contracting entity does not insulate Zhang from personal liability for duties she personally undertook and personally breached.” Taking the argument one step further, the defending party argued that the consulting agreement “does not create a fiduciary relationship even between CoDevCo and Lepu; instead, it identifies CoDevCo as an independent contractor retained to market Lepu’s business to potential western partners.” Although CoDevCo was Lepu’s exclusive business-development contractor, there were no terms stipulating that the consulting firm should serve only Lepu, Zhang’s lawyer noted. As to Lepu’s claims that Zhang misappropriated trade secrets, the defendant argued that Lepu authorized the use of the information so Zhang’s team could perform their service per the agreement. In a rebuttal filed on Sept. 11, Lepu’s lawyer set out why they believe the Chinese biotech satisfied New York law’s misappropriation definition by alleging that the defendant used a trade secret “in breach of a duty or through improper means.” As an alternative to dismissing the suit, the defendant suggested the action should be stayed pending outcomes from the arbitration of a separate case in Singapore. While NewCo pioneer Zhang is defending her business arrangements, momentum behind the NewCo trend has continued unabated into 2026. Through August, Chinese biotech assets have spurred 15 NewCo deals this year, according to local trade publication PharmaDJ.
This “rare” autism-linked genetic disorder may be far more common than scientists thought
A major analysis suggests Phelan-McDermid syndrome, a genetic disorder closely linked to autism, may affect about 1 in 7,300 people and more than 45,000 Americans. Researchers warn that thousands of cases may remain hidden because genetic testing is often not performed, even as targeted treatments move into clinical trials.
CRISPR could help doctors attack blood cancer without destroying healthy cells
Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood cancers without destroying the healthy cells patients need after a transplant. In a 30-patient trial, the edited cells successfully took hold and appeared to shield blood cells from a CD33-targeted cancer treatment.
Alaskans Dismayed, But Not Moved, by Peltola’s Treatment of Her Staff
Voters interviewed in Anchorage and Fairbanks on Thursday said news that Mary Peltola, the Democratic nominee for Senate, had used offensive slurs would not change their vote.
'Primetime' review: Robert Pattinson makes Chris Hansen a scary clown
'To Catch A Predator' gets the 'American Pyscho' treatment.
Taylor Swift 'The Life of a Showgirl Encore' New Tracks Review
A look at the four new tracks added to the "encore" edition of Taylor Swift's 'The Life of a Showgirl.'
Former sports medicine director accused of sexually abusing more than a dozen college athletes
A grand jury indicted Robert Murphy on nine counts of sexual contact under pretext of medical treatment and 23 counts of sexual battery.
Former sports medicine director accused of sexually abusing more than a dozen college athletes
A grand jury indicted Robert Murphy on nine counts of sexual contact under pretext of medical treatment and 23 counts of sexual battery.
Congo faces health worker shortage as Ebola remains out of control, WHO says
Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebola outbreak, particularly in the eastern province of North Kivu where cases have surged 73% over three weeks, the World Health Organization said Wednesday.
Mercy Health to host breast cancer awareness Lunch & Learn Oct. 1
Mercy Health — Paducah will host a free community education event focused on breast cancer prevention, early detection and the latest advances in treatment in recognition of Breast Cancer Awareness
Insurance Coverage Lags as Cancer Science, Treatment Move Forward
Health insurance may not cover experimental targeted therapies for rare cancers, which do not have an established standard of care.
The Changing Practice of Medicine: Keeping Physicians at the Center of Healthcare
By Christopher Chang, MD Medicine is changing, and not simply because of advances in technology, artificial intelligence or new treatments. One of the most significant transformations taking place in healthcare is the way physicians practice medicine and the organizations in which they deliver care. For generations, physician-owned practices were a defining feature of American medicine. […]
Scientists thought they knew how this 70-year-old leukemia drug worked
A 70-year-old leukemia drug is still revealing new secrets. Researchers found that removing a protein called NUDT5 protected cells from the drug, even though simply blocking the protein had little effect. The unexpected result points to a hidden cellular role that could help explain why people respond differently to certain leukemia treatments.
Mental and Behavioral Health Profiles – Memorial Regional Hospital’s Outpatient Behavioral Health Center
Driven by a desire to make a lasting difference, Elizaveta “Liza” Houellemont, LMHC, chose a career in mental health to help people build healthier relationships with themselves and create more fulfilling lives. Working in substance use treatment, she finds the greatest reward in seeing patients commit to recovery and experience meaningful transformation. As a licensed […]
New emergency department screening helps UK HealthCare identify sepsis sooner
A new emergency department screening protocol at UK HealthCare is helping care teams identify sepsis earlier and begin treatment more quickly, improving care for a life-threatening condition where every minute matters.
Chicago launches street psychiatry teams to bring mental health treatment to the homeless
The Chicago Department of Public Health on Wednesday launched its first "street psychiatry" teams, in an effort to provide mental health services to some of the city's most vulnerable people.
UVA Health study examines incision-less liver tumor treatment
UVA Health researchers reviewed outcomes from nearly 1,000 patients treated with a procedure called histotripsy.
Downtown Detroit stabbing suspect court ordered to undergo mental health treatment before deadly attack
Vanderbilt Health study identifies drugs with potential to improve outcomes associated with preterm labor
A team of Vanderbilt Health investigators has identified drugs with previously unrecognized potential as treatments for preterm labor.
Tampa General Hospital First Academic Health System in Southeast to Adopt Innovative Host-Response Technology to Advance Sepsis Care
MeMed BV provides results in 15 minutes to help clinicians distinguish bacterial from viral infections, building on Tampa General’s nationally recognized efforts to improve the early detection and treatment of sepsis. Sept. 22, 2026 – Tampa General Hospital (TGH) is advancing its longstanding commitment to improving sepsis care as the first academic health system in the Southeast to […]
Brandi Glanville’s Never-Ending Health Battle Gets Yolanda Hadid Assist
Brandi Glanville has received support from her former RHOBH costar Yolanda Hadid as she continues treatment for a mysterious facial condition. The 53-year-old said the issue began after she filmed Rea...
California Seeks to Implement AI Guardrails for Mental Health Treatment
A bill has been unanimously passed by the California Senate that seeks to establish common-sense guardrails for artificial intelligence (AI) use in mental A bill has been passed by the California legislature that sets common sense guardrails for Artificial intelligence in mental health treatment. The bill now awaits the signature of the state governor.
Gloria Reuben Urges Menopausal Women to Advocate for Their Health
VEOZAH™ (fezolinetant) is a first-of-its-kind, FDA-approved treatment for moderate to severe hot flashes due to menopause
Variety – the Children’s Charity awards grants to 104 Iowa nonprofits
Variety – the Children’s Charity has selected 104 nonprofits across Iowa to receive funding through its annual grant program. The funding supports projects and services for children and families across the state, including organizations serving local communities and nonprofits with a statewide reach. Variety provides funding for organizations that deliver care, treatment, activities and shelter…
Scientists Built a Paper-Based Battery You Can Swallow. It Could Power Medical Pills for Days
The tiny battery could help doctors track treatment and deliver medicine.
Congo is running short of health workers as Ebola remains out of control, WHO says
BUNIA, Congo (AP) — Congo is running short of health workers to staff treatment centers for history's fastest-growing Ebola outbreak, particularly in the eastern province of North Kivu where cases have surged 73% over three weeks, the World Health Organization said Wednesday.
Roche Canada and Health Data Research Network Canada Announce First-of-its-Kind Partnership Focused on Pediatric Multiple Sclerosis Care
Hoffmann-La Roche Limited (Roche Canada) and Health Data Research Network Canada (HDRN Canada) today announced a novel partnership that uses health data from multiple provinces to better understand pediatric multiple sclerosis (MS) treatments and care across Canada. It marks HDRN Canada's first private-sector project and Roche Canada's first collaboration with HDRN Canada on multi-provincial health data research.
Insurance Coverage Lags as Cancer Science, Treatment Move Forward
By Arthur Allen Sep 22, 2026 Mason Henderson with his mother, Tabitha Lowe, in November 2025 during a visit to New York, where Henderson was participating in a clinical trial to treat his brain cancer. Henderson died in May 2026 after a two-year battle with the disease. (Jerry Lowe) Mason Henderson with his mother, Tabitha…
NEUPATH HEALTH TO HOST ANNUAL PHYSICIAN FORUM FOCUSED ON CLINICAL EDUCATION
TORONTO, September 23, 2026--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain-related medical services, today announced that it will host its annual Physician Forum from September 25 to 27, 2026, at Fairmont Le Château Montebello in Montebello, Québec.